Home/Filings/4/0001048477-23-000051
4//SEC Filing

Guyer Charles Greg 4

Accession 0001048477-23-000051

CIK 0001048477other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:59 PM ET

Size

311.7 KB

Accession

0001048477-23-000051

Insider Transaction Report

Form 4
Period: 2023-12-01
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
  • Award

    Common Stock

    2023-12-01+11,84052,014 total
  • Award

    Common Stock

    2023-10-31$69.23/sh+133$9,20840,174 total
Footnotes (2)
  • [F1]Represents the shares acquired by the reporting person on October 31, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
  • [F2]Restricted stock units granted on December 1, 2023. Price not applicable.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001811096

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:59 PM ET
Size
311.7 KB